Mirae Asset Global Etfs Holdings Ltd. Biogen Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 144,593 shares of BIIB stock, worth $18.8 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
144,593
Previous 117,240
23.33%
Holding current value
$18.8 Million
Previous $17.9 Million
10.36%
% of portfolio
0.05%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding BIIB
# of Institutions
1,026Shares Held
127MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.21 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2.07 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.89 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$960 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$606 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...